Clinical trial
Investigating Idiopathic Pulmonary Fibrosis in Greece
NCT03074149 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Investigating Idiopathic Pulmonary Fibrosis in Greece
- Lead sponsor
- Boehringer Ingelheim
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 4, 2017
- Completion date
- March 30, 2021
- Enrollment
- 301 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.